KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Management of second ipsilateral breast tumor event: An advocacy for a randomized trial.

J-M Hannoun-Lévi, A Savignoni, J-G Féron, C Malhaire, C Ezzili, A Brédart, P Loap, Y Kirova

Cancer Radiother 28(2) 188-194

PMID38216433
PMCID-
DOI10.1016/j.canrad.2023.11.001
发表日期2024-01-12
摘要

摘要

For a second ipsilateral breast tumor event, salvage mastectomy is the standard of care while second conservative treatment is a possible option. However, level 1 proofs are missing, leading to perform salvage mastectomy for patients who could receive second conservative treatment and consequently avoid psychological/quality of life salvage mastectomy deleterious impacts. A phase 3 randomized trial comparing salvage mastectomy to second conservative treatment is needed. Here we discuss what would be to us the optimal design of such trial to confirm the non-inferiority between the two salvage options, with a focus on methodological aspects in terms of patient characteristics and statistical issues.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。